Matches in SemOpenAlex for { <https://semopenalex.org/work/W58356907> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W58356907 abstract "Abstract Enzyme Replacement Therapy (ERT) has dramatically changed the clinical course and prognosis of patients with Gaucher disease. We have assessed the extent to which the recently defined Goals of Therapy (Pastores et al, Semin Hematol 41(suppl 5):4–14) in 9 major fields (anemia, thrombocytopenia, hepatomegaly, splenomegaly, skeletal pathology,biomarkers, pulmonary manifestations, growth and functional health and well being) were achieved in our cohort of patients with type I Gaucher disease. Fifty-seven patients (27 females, 30 males, median age at diagnosis 30 years (range 2–77 years) and at start of ERT 39 years (range 5–79 years) were assessed. The median period of ERT was 94 months (range 24–155 months). Patients on ERT for less than 2 years were excluded. Twenty five specific goals are defined within the 9 fields. The median overall success rate was 20 of 25 goals or 80% per patient (range 12–25 goals or 60–100%). The success rate for 9 goals was 100% ( normalization of hemoglobin 1 year post-splenectomy, no major bleeding 1 year after ERT start, doubling of baseline platelet count in severely thrombocytopenic patients 2 years after ERT start, maintenance of platelet count in non-thrombocytopenic patients, prevention of bone crises, reversion of hepatopulmonary syndrome and dependence on oxygen, amelioration of pulmonary hypertension and prevention of rapid deterioration of pulmonary disease and sudden death). Higher success rates were achieved for the goals related to thrombocytopenia (97.9%) and pulmonary manifestations (97%) although in the latter case the applicability was low. Lower success rates were achieved for the goals related to bone manifestations (78.7%). There was no significant difference in the success rate between males and females, splenectomised and non-splenectomised patients, and between patients treated less or more than 6 years. However patients started on ERT before the 40th year of age exhibited significantly higher success rate as compared to patients started after the 40th year (p=0.047) and there was a significant inverse correlation between overall success rate and patient’s age at treatment start (r = − 0.437). Finally, the success rate was higher among double heterozygotes, carrying the N370S mutation, as compared to patients homozygous for the N370S mutation (89.2±9.6% vs. 80.2±12.9%, p=0.016)." @default.
- W58356907 created "2016-06-24" @default.
- W58356907 creator A5004305596 @default.
- W58356907 creator A5016812185 @default.
- W58356907 creator A5024894157 @default.
- W58356907 creator A5024960041 @default.
- W58356907 date "2006-11-16" @default.
- W58356907 modified "2023-09-27" @default.
- W58356907 title "Variation of Serum Lipid Profile during Enzyme Replacement Therapy, in Patients with Type 1 Gauchers Disease." @default.
- W58356907 doi "https://doi.org/10.1182/blood.v108.11.3849.3849" @default.
- W58356907 hasPublicationYear "2006" @default.
- W58356907 type Work @default.
- W58356907 sameAs 58356907 @default.
- W58356907 citedByCount "0" @default.
- W58356907 crossrefType "journal-article" @default.
- W58356907 hasAuthorship W58356907A5004305596 @default.
- W58356907 hasAuthorship W58356907A5016812185 @default.
- W58356907 hasAuthorship W58356907A5024894157 @default.
- W58356907 hasAuthorship W58356907A5024960041 @default.
- W58356907 hasConcept C126322002 @default.
- W58356907 hasConcept C141071460 @default.
- W58356907 hasConcept C187212893 @default.
- W58356907 hasConcept C2776309230 @default.
- W58356907 hasConcept C2778248108 @default.
- W58356907 hasConcept C2779134260 @default.
- W58356907 hasConcept C2779969927 @default.
- W58356907 hasConcept C2780930700 @default.
- W58356907 hasConcept C2780931953 @default.
- W58356907 hasConcept C71924100 @default.
- W58356907 hasConcept C90924648 @default.
- W58356907 hasConceptScore W58356907C126322002 @default.
- W58356907 hasConceptScore W58356907C141071460 @default.
- W58356907 hasConceptScore W58356907C187212893 @default.
- W58356907 hasConceptScore W58356907C2776309230 @default.
- W58356907 hasConceptScore W58356907C2778248108 @default.
- W58356907 hasConceptScore W58356907C2779134260 @default.
- W58356907 hasConceptScore W58356907C2779969927 @default.
- W58356907 hasConceptScore W58356907C2780930700 @default.
- W58356907 hasConceptScore W58356907C2780931953 @default.
- W58356907 hasConceptScore W58356907C71924100 @default.
- W58356907 hasConceptScore W58356907C90924648 @default.
- W58356907 hasLocation W583569071 @default.
- W58356907 hasOpenAccess W58356907 @default.
- W58356907 hasPrimaryLocation W583569071 @default.
- W58356907 hasRelatedWork W1850320178 @default.
- W58356907 hasRelatedWork W1964215666 @default.
- W58356907 hasRelatedWork W1983354021 @default.
- W58356907 hasRelatedWork W2166718278 @default.
- W58356907 hasRelatedWork W2168903900 @default.
- W58356907 hasRelatedWork W2223628101 @default.
- W58356907 hasRelatedWork W2362711653 @default.
- W58356907 hasRelatedWork W2441852077 @default.
- W58356907 hasRelatedWork W4230158896 @default.
- W58356907 hasRelatedWork W88613777 @default.
- W58356907 isParatext "false" @default.
- W58356907 isRetracted "false" @default.
- W58356907 magId "58356907" @default.
- W58356907 workType "article" @default.